Document Detail


The association between upper gastrointestinal lesions and high-sensitivity C-reactive protein in coronary artery disease patients.
MedLine Citation:
PMID:  19179966     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Although high-sensitivity C-reactive protein (hs-CRP) testing is not specific for coronary atherosclerosis, elevated hs-CRP is recently accepted as an independent predictor of future cardiovascular events. Also, a connection between upper gastrointestinal lesions (UGILs) and coronary artery disease (CAD) has been observed. The authors hypothesized that UGILs increase hs-CRP in CAD patients. MATERIAL/METHODS: One hundred fifty patients with stable CAD were enrolled in the study. Demographic and clinical variables and chronic medication used were gathered from a structured questionnaire. UGIL severity was determined by a modified Lanza score, H. pylori status by histology of the gastric mucosa, and the severity of CAD by a modified Gensini score. Independent correlation between hs-CRP and UGIL was tested by logistic regression analysis. RESULTS: The overall hs-CRP value was higher in patients with UGIL than in those with normal endoscopic results (8.14+/-4.53 mg/l vs. 4.64+/-3.06 mg/l, P<0.0001). hs-CRP level positively correlated with UGIL severity (r=0.434, P<0.0001). Correlation between UGIL and hs-CRP level remained significant after adjustment for coronary risk factors, medication used, CAD severity, and H. pylori status (standardized coefficient beta=1.272, P<0.0001). However, when hs-CRP level was used as a categorical variable, multivariate analysis revealed independent correlation only between UGIL and hs-CRP categories > or =6.1 mg/l. CONCLUSIONS: Elevated hs-CRP levels may be predictive of UGIL; thus endoscopy should be considered in CAD patients with elevated hs-CRP even with no dyspeptic symptoms. Because CRP plays an active role in atherothrombosis, UGILs with subsequent elevated CRP levels could increase cardiovascular risk in those patients.
Authors:
Damir Fabijanić; Marko Banić; Dusko Kardum; Zeljko Sutlić; Miroslav Simunić; Damir Bonacin; Zeljko Romić; Lidija Petricusić; Milan Kujundzić
Related Documents :
12153546 - Serum homocysteine, creatinine, and glucose as predictors of the severity and extent of...
496636 - Routine coronary angiography prior to elective aortic reconstruction: results of select...
7363316 - Myocardial ischemia after left ventriculography: pathophysiology and clinical significa...
19073376 - Comparison of automated 4d-mspect and visual analysis for evaluating myocardial perfusi...
17583376 - Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use.
16555576 - The risk of cardiovascular events in japanese hypertensive patients with hypercholester...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Medical science monitor : international medical journal of experimental and clinical research     Volume:  15     ISSN:  1643-3750     ISO Abbreviation:  Med. Sci. Monit.     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-01-30     Completed Date:  2009-04-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9609063     Medline TA:  Med Sci Monit     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  CR45-50     Citation Subset:  IM    
Affiliation:
University Hospital Split, Split, Croatia. damir.fabijanic@st.t-com.hr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
C-Reactive Protein / metabolism*
Coronary Artery Disease / complications*,  metabolism*
Dyspepsia / complications
Female
Gastrointestinal Diseases / complications*,  metabolism
Humans
Male
Middle Aged
Regression Analysis
Chemical
Reg. No./Substance:
9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Does the dynamicity of weight gain predict elements of metabolic syndrome? Differences in weight gai...
Next Document:  Incubation with DNase I inhibits tumor cell proliferation.